Guardant Health Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Guardant Health Inc inventory turnover ratio, the Guardant Health Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 4.41 in the first quarter 2026, a new company high. Average inventory processing period, for the Guardant Health Inc in Mar 31 2026 quarter, has decreased to 83 days, compare to 88 days, in the Dec 31 2025 quarter.

Within Healthcare sector 82 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 339 in the fourth quarter 2025, to 731.

GH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Guardant Health Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GH Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	8.54 %	20.81 %	25.16 %	25.49 %	22.65 %
Y / Y Cost of Sales Growth	40.41 %	-	25.64 %	12.13 %	14.44 %
Inventory Turnover Ratio (TTM)	4.41	4.13	3.09	3.02	3.08
GH's Total Ranking	# 731	# 339	# 342	# 437	# 0
Average inventory processing period	83	88	118	121	118
Seq. Inventory Growth	-2.36 %	-5.1 %	7.65 %	8.81 %	8.68 %
Seq. Cost of Sales Growth	5.45 %	6.31 %	15.25 %	8.67 %	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Laboratories Industry	# 7
Healthcare Sector	# 83
Overall Market	# 731

Inventory Turnover Ratio Statistics
High	Average	Low
4.41	2.76	0.99
(Mar 31 2026)		(Mar 31 2024)

GH Company Profile >> Back to GH Efficiency Comparisons >> Compare GH Inventory Turnover Ratio to its Competitors

Financial Statements
Guardant Health Inc 's Inventories	$ 84 Millions	Visit GH's Balance sheet
Guardant Health Inc 's Cost of Revenues TTM	$ 379 Millions	Visit GH's Income Statement
What are GH's Sales?		Visit GH's Sales by Segment

Other Inventory Turnover Ratios
Guardant Health Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
GH's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for GH's Competitors
Inventory Turnover Ratio for GH's Suppliers
Inventory Turnover Ratio for GH's Customers

You may also want to know
GH's Sales Growth Rates	GH's Pe Price to earnings ratio	GH's Receivables Turnover Ratio	GH's Stock Quote
GH's Net Income Growth Rates	GH's Ps Price to Sales ratio	GH's Sales per Employee	GH's Asset Turnover Ratio
GH's Net Margin	GH's Pb Price to Book ratio	GH's Financial Strength Ratios	GH's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
The Oncology Institute Inc	11.17	$ 211.805 Millions	$ 19 Millions
Genedx Holdings Corp	11.09	$ 135.000 Millions	$ 12 Millions
Infusystem Holdings Inc	10.96	$ 61.593 Millions	$ 6 Millions
Irhythm Holdings Inc	10.94	$ 228.000 Millions	$ 21 Millions
Earth Science Tech Inc	10.81	$ 8.224 Millions	$ 1 Millions
Option Care Health Inc	10.74	$ 4,579.720 Millions	$ 427 Millions
Zevra Therapeutics Inc	10.44	$ 17.034 Millions	$ 2 Millions
Alnylam Pharmaceuticals Inc	10.38	$ 814.503 Millions	$ 78 Millions
Nutriband Inc	10.06	$ 1.291 Millions	$ 0 Millions
Lantheus Holdings Inc	9.75	$ 610.000 Millions	$ 63 Millions
Sotera Health Company	9.58	$ 531.000 Millions	$ 55 Millions
Warby Parker Inc	9.23	$ 415.000 Millions	$ 45 Millions
National Vision Holdings Inc	8.90	$ 833.415 Millions	$ 94 Millions
Myriad Genetics Inc	8.35	$ 248.000 Millions	$ 30 Millions
Pulse Biosciences Inc	8.08	$ 0.909 Millions	$ 0 Millions
Castle Biosciences Inc	7.97	$ 75.178 Millions	$ 9 Millions
Moderna Inc	7.96	$ 1,733.000 Millions	$ 218 Millions
Carlsmed Inc	7.95	$ 12.557 Millions	$ 2 Millions
Inogen Inc	7.80	$ 195.741 Millions	$ 25 Millions
Cardiff Lexington Corporation	7.70	$ 4.159 Millions	$ 1 Millions
Novavax inc	7.67	$ 89.620 Millions	$ 12 Millions
Prophase Labs Inc	7.64	$ 2.361 Millions	$ 0 Millions
Bellevue Life Sciences Acquisition Corp	7.62	$ 1.985 Millions	$ 0 Millions
Lifemd Inc	7.60	$ 24.000 Millions	$ 3 Millions
Tarsus Pharmaceuticals Inc	7.60	$ 31.627 Millions	$ 4 Millions
Charles River Laboratories International inc	7.56	$ 2,346.239 Millions	$ 310 Millions
Adaptive Biotechnologies Corporation	7.43	$ 73.088 Millions	$ 10 Millions
Puma Biotechnology Inc	7.19	$ 58.025 Millions	$ 8 Millions
Fonar Corporation	7.06	$ 19.685 Millions	$ 3 Millions
Carlisle Companies Incorporated	6.71	$ 3,206.100 Millions	$ 478 Millions

Date modified: 2026-08-29T17:40:14+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.